Bulbar Urethral Syndrome: Decoding Bladder Bowel Dysfunction

Ansari M1, YADAV D1

Research Type

Clinical

Abstract Category

Paediatrics

Abstract 536
Open Discussion ePosters
Scientific Open Discussion Session 105
Friday 19th September 2025
12:45 - 12:50 (ePoster Station 2)
Exhibition
Bowel Evacuation Dysfunction Voiding Dysfunction Pediatrics
1. Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, India
Presenter
Links

Abstract

Hypothesis / aims of study
Bladder bowel dysfunction (BBD) is a combination of bladder and bowel disturbances in children who have no identifiable or recognizable neurologic abnormality. In BBD the entire pelvic floor is dysfunctional,  bladder and bowel are  just a part of it.
We here in describe that the muscular component (bulbospongiosus muscle [BSM]) of the pelvic floor may substantially contribute to the voiding disorder children.
Study design, materials and methods
Study includes all children presented to us with lower urinary tract (LUTS) and bowel symptoms (constipation / incontinence).   After ruling out of any other causes of symptoms like neurogenic or structural abnormality, bladder and bowel diaries with uroflowmetry and pelvic floor EMGs (Fig. 1) were assessed.   The children who continued to have persistent LUTS even after 3 months of Urotherapy were further subjected to pelvic floor functional MRI (FrMRI) (Fig. 2) and high-resolution anorectal manometry (HRAM) to study the anatomy and physiology of pelvic floor muscular components with special reference to bulbospongiosus muscle.
Dysfunctional voiding score system (DVSS) was obtained at start of the  treatment which was also used for the monitoring of symptoms.  
Management included Urotherapy along with EMG biofeedback and   bowel program.
Results
Between January 2015 and December 2023, a total of 110 children with median age of 7.5 yrs (range 3.5-12) diagnosed with BBD were included in the study.  Of these 25 (22.7%) children who failed to show improvement after Urotherapy were counselled for Fr MRI and HRAM.   Fifteen   of them accepted.  The Fr MRI during voiding showed occlusive contraction of bulbospongiosus in these children (Fig. 2). HRAM also recorded high anal pressure while attempting for evacuation (Fig. 3). 
The 4 (33.3%) children responded to first line (Targeted Urotheray) and rest 8 (67.7%) needed second line of management (Botulinum toxin, Neuromodulation and Pharmacotherapy). The Median DVSS symptom score of was 15   and 6 before and after treatment (p value 0.31). The DVSS score and total QOL score were statistically correlated (r = 0.281, p = 0.05).
Interpretation of results
The Fr MRI during voiding showed occlusive contraction of bulbospongiosus in   children with BBD (Fig. 2). HRAM also recorded high anal pressure while attempting for evacuation (Fig. 3). The authors  hypothesize that    the muscular component (bulbospongiosus muscle [BSM]) of the pelvic floor may substantially contribute to the voiding disorder children.
Targeted Urotheray showed good response in 4 (33.3%) children   and rest 8 (67.7%) needed more aggressive second line of management (Botulinum toxin, Neuromodulation and Pharmacotherapy).
Concluding message
In lower urinary tract dysfunction (LUTD) in children one need to look beyond the bowel and bladder involvement. Other muscular component of the pelvic floor may substantially contribute to the similar voiding disorder. When suspected these children should undergo more elaborate work up to achieve the best therapeutic goals.
Figure 1 Uroflowmetry and pelvic floor EMG showing non- relaxing external sphincter
Figure 2 Functional MRI done during micturition showing compression of bulbospongiosus muscle and excessive kink at urethrovesical angle
Figure 3 Anorectal manometry: inadequate intra-abdominal pressure during straining, incomplete evacuation of the rectum, and inadequate relaxation of anal canal pressures
References
  1. Austin et al. Neurourology and Urodynamics. 2014
  2. G Currarino. Am J Roentgenol Radium Ther Nucl Med., 1970 Mar;108(3):641-7
  3. Chiarioni et al., Gastroenterology. 2005; 129:86–97
Disclosures
Funding None Clinical Trial Yes Registration Number 2014/02317/CL RCT No Subjects Human Ethics Committee 2015-BBD-65 Helsinki Yes Informed Consent Yes
16/07/2025 07:21:00